Dietz Thomas John — SEC insider filings

SEC reporting owner CIK 1574218. 23 insider filings on record with FilingPulse; latest filed 2026-08-27.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2020-08-12 to 2026-08-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Eiger BioPharmaceuticals, Inc. (EIGR)Director63 legs · 52,500 sh · $92,8001 leg · 22,500 sh · $26,3025
CYPHERPUNK TECHNOLOGIES INC. (CYPH)Director13—1 leg · 20,000 sh · $34,40016
Paratek Pharmaceuticals, Inc. (PRTK)Director4——13

Insider filings — Dietz Thomas John

FiledFormIssuerReported transactionsSource
2026-08-274CYPHERPUNK TECHNOLOGIES INC. (CYPH)Sale (S): 20,000 @ $1.72EDGAR
2026-07-024CYPHERPUNK TECHNOLOGIES INC. (CYPH)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2026-03-174CYPHERPUNK TECHNOLOGIES INC. (CYPH)Option exercise (M): 104,500 · Option exercise (M): 104,500 (derivative) @ $0EDGAR
2025-12-304CYPHERPUNK TECHNOLOGIES INC. (CYPH)Option exercise (M): 83,000 · Tax withholding (F): 35,000 @ $1.20 · Option exercise (M): 83,000 (derivative) @ $0 · Grant/award (A): 104,500 (derivative) @ $0EDGAR
2025-11-134CYPHERPUNK TECHNOLOGIES INC. (CYPH)Grant/award (A): 83,000 (derivative) @ $0EDGAR
2024-10-044LEAP THERAPEUTICS, INC. (LPTX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-01-314LEAP THERAPEUTICS, INC. (LPTX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-09-214Paratek Pharmaceuticals, Inc. (PRTK)Disposition to issuer (D): 49,250 · Disposition to issuer (D): 20,000 · Disposition to issuer (D): 7,000 (derivative) · Disposition to issuer (D): 7,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +3 moreEDGAR
2023-08-254LEAP THERAPEUTICS, INC. (LPTX)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2023-04-044LEAP THERAPEUTICS, INC. (LPTX)Grant/award (A): 175,000 (derivative) @ $0EDGAR
2023-03-034Eiger BioPharmaceuticals, Inc. (EIGR)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2023-02-094Paratek Pharmaceuticals, Inc. (PRTK)Grant/award (A): 20,000 @ $0EDGAR
2023-01-254Eiger BioPharmaceuticals, Inc. (EIGR)Purchase (P): 50,000 @ $1.43EDGAR
2022-12-274Eiger BioPharmaceuticals, Inc. (EIGR)Sale (S): 22,500 @ $1.17EDGAR
2022-09-024LEAP THERAPEUTICS, INC. (LPTX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2022-03-114Eiger BioPharmaceuticals, Inc. (EIGR)Grant/award (A): 6,000 @ $0 · Grant/award (A): 24,000 (derivative) @ $0EDGAR
2022-02-184Paratek Pharmaceuticals, Inc. (PRTK)Grant/award (A): 20,000 @ $0EDGAR
2022-02-024LEAP THERAPEUTICS, INC. (LPTX)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2021-04-124Eiger BioPharmaceuticals, Inc. (EIGR)Purchase (P): 1,500 @ $8.48 · Purchase (P): 1,000 @ $8.50EDGAR
2021-03-154Eiger BioPharmaceuticals, Inc. (EIGR)Grant/award (A): 5,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-02-224Paratek Pharmaceuticals, Inc. (PRTK)Grant/award (A): 9,000 @ $0 · Grant/award (A): 7,000 (derivative) @ $0EDGAR
2021-01-064LEAP THERAPEUTICS, INC. (LPTX)Grant/award (A): 37,300 (derivative) @ $0EDGAR
2020-08-124LEAP THERAPEUTICS, INC. (LPTX)Grant/award (A): 12,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1574218 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs